[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353432-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353432-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","allee-effect-and-oncolytic-virotherapy-different-therapeutic-outcomes-for-different-tumour-growth","Allee Effect and Oncolytic Virotherapy: Different Therapeutic Outcomes for Different Tumour Growth","","Tumour recurrence after oncolytic virotherapy is a key clinical barrier for solid cancers, since tumour populations can persist and spread after treatment. Many mathematical models assume growth without cooperative cell behaviours, yet the Allee effect can reshape low-density dynamics and therapy results. This work integrates Allee effects into logistic and Gompertz growth frameworks and shows density-dependent cooperation changes virotherapy efficacy, enabling pseudo-extinction under weak effects and bistability under strong effects. Bifurcation analysis indicates initial tumour burden and small shifts in infection or clearance can switch outcomes, while the Gompertz model yields multistability near marginal thresholds. These findings support dosing schedule adjustment and quantitative guidance for patient-specific and combination regimens.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/allee-effect-and-oncolytic-virotherapy-different-therapeutic-outcomes-for-different-tumour-growth/353432/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/allee-effect-and-oncolytic-virotherapy-different-therapeutic-outcomes-for-different-tumour-growth/353432.png","ImageObject",300,407,{"name":42,"@type":43},"acoobca","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is tumour recurrence a critical challenge after oncolytic virotherapy?","Question",{"text":63,"@type":64},"Solid cancers tend to persist and spread after oncolytic virotherapy, making recurrence and therapeutic resistance central clinical problems.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the Allee effect change virotherapy outcomes in the model?",{"text":68,"@type":64},"Density-dependent cooperation alters virotherapy efficacy: weak Allee effects can drive pseudo-extinction (tumours collapse to undetectable levels), while strong effects can produce bistable, non-trivial outcomes.",{"name":70,"@type":61,"acceptedAnswer":71},"What factors most influence whether outcomes shift dramatically?",{"text":72,"@type":64},"Initial tumour burden is determinant; bifurcation analysis shows that modest increases in infection or decreases in clearance rates can switch outcomes between different regimes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353432,1791170630,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":108,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Bulletin of Mathematical Biology (2026) 88:172 [https://doi.org/10.1007/s1](https://doi.org/10.1007/s1)1538-026-01746-9  \nORIGINAL RESEARCH  \nAllee Effect and Oncolytic Virotherapy: Different Therapeutic Outcomes for Different Tumour Growth  \nJiawen Chen1 · Federico Frascoli1 · Tonghua Zhang1  \nReceived: 14 March 2026 / Accepted: 18 August 2026 © The Author(s) 2026  \nAbstract  \nTumour recurrence after oncolytic virotherapy is a critical clinical challenge, as solid cancers tend to persist and spread after such therapies alone. Often, mathematical models consider tumour growth without taking possible cooperative cell behaviours into account. Instead, the well-known Allee effect has the ability to drive low-density tumour dynamics and affect therapeutic outcomes. For this reason, we here explore the contribution of Allee effects into two of the most common cancer growth paradigms, e.g. the logistic and the Gompertz frameworks. Our analysis reveals that densitydependent cooperation fundamentally alters virotherapy efﬁcacy. Weak effects can enable pseudo-extinction states where tumour populations collapse to undetectable levels, whilst strong effects can interestingly create non trivial, bistable outcomes. Initial tumour burden seems to be determinant: bifurcation analysis shows scenarios where modest increase in infection or decrease in clearance rates can shift outcomes dramatically. Notably, the Gompertz model exhibits multistability under marginal Allee thresholds, pointing at a possible explanation for spontaneous remission that have been clinically observed. Overall, these ﬁndings suggest that Allee effects maybe an important factor in the future to adjust dosing schedules, reduce viral loads, lower recurrence risk and shorten therapeutic times. Our framework may also offer quantitative guidance for patient-speciﬁc regimes for virotherapy and combination therapies.  \nKeywords Tumour · Oncolytic virotherapy · Allee effect · Tumour growth · Therapeutic outcomes  \nB Federico Frascoli [ffrascoli@swin.edu.au](ffrascoli@swin.edu.au)  \nB Tonghua Zhang [tonghuazhang@swin.edu.au](tonghuazhang@swin.edu.au)  \nJiawen Chen  \n[cjw2019@foxmail.com](cjw2019@foxmail.com)  \n1 Department of Mathematics, Swinburne University of Technology, John Street, Hawthorn, VIC 3122, Australia  \n1 3  \n1 Introduction  \nCancer remains a leading cause ofmortality worldwide, with treatment failure predominantly driven by recurrence and therapeutic resistance. Surgery, chemotherapy and radiotherapy are established techniques employed against tumours, whereas oncolytic virotherapy (OVT), although the effects of infections on tumours have been known for more than a century, still has not fully translated from trials to clinics. OVT emerged as a possible clinical approach a few decades ago, with the rise in genetical engineering and the ability of creating viruses that selectively infect and destroy cancer cells (Ribas et al. 2017; Zhong et al. 2025) . Recently, its ability to also elicit targeted immune responses, co-adjuvate immunotherapy and combat immune evasion have emerged, with some encouraging yet incomplete results in preclinical and murine models (Chen et al. 2024; Nguyen et al. 2022b; Yun et al. 2022; Jhawar et al. 2023 ; Yang et al. 2025; Xuan et al. 2025) . Despite decades of promises, achieving complete remission in most common types of tumours remains a fundamental challenge, especially if OVT is used in isolation, e.g., without the help of other techniques.  \nMathematical modeling has been very helpful in characterising the dynamics and the typical outcomes of tumours under different OVTs. For example, deterministic models reveal dose-response thresholds (Wodarz 2001; Komarova and Wodarz 2010; Guo and Dobrovolny 2023; Ramaj andZou 2023) and stochastic frameworks show the effect of tumour heterogeneity on viral extinction (Yuan and Allen 2011; Rajalakshmi and Ghosh 2018; Camara et al. 2022; Morselli et al. 2026a) . Spatial models explained oscillato","cbCaib4RWJTPB8mH","https://ap.wps.com/l/cbCaib4RWJTPB8mH","pdf",1725551,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"Why is tumour recurrence a critical challenge after oncolytic virotherapy?\",\"answer\":\"Solid cancers tend to persist and spread after oncolytic virotherapy, making recurrence and therapeutic resistance central clinical problems.\"},{\"question\":\"How does the Allee effect change virotherapy outcomes in the model?\",\"answer\":\"Density-dependent cooperation alters virotherapy efficacy: weak Allee effects can drive pseudo-extinction (tumours collapse to undetectable levels), while strong effects can produce bistable, non-trivial outcomes.\"},{\"question\":\"What factors most influence whether outcomes shift dramatically?\",\"answer\":\"Initial tumour burden is determinant; bifurcation analysis shows that modest increases in infection or decreases in clearance rates can switch outcomes between different regimes.\"}]","Allee Effect and Oncolytic Virotherapy: Different Therapeutic Outcomes for Different Tumour Growth | PDF",1790105369,101,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32307651c31af60a79b4c5316c2a8a40.webp",983,1415,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92c03cd8ae76b3efa29a8de0120de675.webp",982,1414,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f415354bbfd977411bfcf3bc6dcec20.webp",981,1412,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08a15bed1559b9edc0ad3e57a93b34d7.webp",980,1411]